Literature DB >> 16506362

A novel LC-IDMS/MS method for the determination of the cardiac glycosides digoxin and digitoxin using caesium adducts.

Patricia Kaiser1, Theodorus Akerboom, William Graham Wood, Hans Reinauer.   

Abstract

This article describes an essential improvement of the published candidate reference measurement procedure for digoxin and digitoxin and compares it with the original method. The novelty of the method lies in the measurement of the caesium (Cs+) ion as product ion in the multiple reaction monitoring mode (MRM) with potentially improved analytical specificity whilst retaining a comparable accuracy and precision at therapeutic levels. The original measurement procedure used the single-ion mode (SIM). The dissociation of the Cs+ adducts in MRM leads to the formation of Cs+ ions as main charged product in high yield. The present method results in a product ion signal intensity in MRM for digoxin and digitoxin of up to 80% of the precursor ion signal intensity in SIM. The precision, expressed as the coefficient of variation of the new method for digoxin was 3.18% (SIM) and 2.28% (MRM) at a concentration of 0.66 microg/l and 1.26% (SIM) or 1.65% (MRM) at 2.0 microg/l. The corresponding data for digitoxin were 1.21% (SIM) and 1.62% (MRM) at 24 microg/l and 1.46% (SIM) and 1.13% (MRM) at 42 microg/l.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506362

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  2 in total

1.  LC-MS assay for quantitative determination of cardio glycoside in human blood samples.

Authors:  L Frommherz; H Köhler; B Brinkmann; M Lehr; J Beike
Journal:  Int J Legal Med       Date:  2007-06-14       Impact factor: 2.686

2.  A new approach for the determination of immunosuppressive drugs using HPLC-MS/MS and Cs+ adducts.

Authors:  Patricia Kaiser; Theodorus Akerboom; William Graham Wood; Hans Reinauer
Journal:  Ger Med Sci       Date:  2006-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.